Jeff BousfieldSector leader
chief executive of Nonacus, the biotech firm behind the Galeas bladder test
Cited in UK press coverage of health & social care
1 citation
Across 1 topic, first on 27 Aug 2026.
Expertise
Cited on
What they’ve said
“It hoped to improve the test's 92% accuracy further as its NHS rollout continued, he added.”
chief executive of Nonacus, the biotech firm behind the Galeas bladder test · Hospital discharge / bed-blocking · 27 Aug 2026 · NHS hospitals adopt faster, more accurate at-home bladder cancer test ↗
Source references
- NHS hospitals adopt faster, more accurate at-home bladder cancer testtheguardian.com · 27 Aug 2026
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.